Crédit Industriel et Commercial’s Exact Sciences EXAS Stock Holding History

Crédit Industriel et Commercial’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,000	Closed	-$433K	–	397
2025 Q1	$433K	Buy	+10,000	New	+$506K	0.05%	284

Other funds holding EXAS

VanEck Associates

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Crédit Industriel et Commercial's EXAS Position: Q1 2026 in Review

Crédit Industriel et Commercial sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2,474 shares — an estimated $251K sold.

Crédit Industriel et Commercial first reported a position in EXAS in Q1 2025 and held it in 2 quarters. The position peaked at $336K in Q1 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Crédit Industriel et Commercial reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Crédit Industriel et Commercial sold 2,474 Exact Sciences shares in Q1 2026, an estimated $251K.
Crédit Industriel et Commercial first reported a position in Exact Sciences in Q1 2025 and held it in 2 quarters.
Crédit Industriel et Commercial's Exact Sciences position peaked at $336K in Q1 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Crédit Industriel et Commercial's 13F filing for Q1 2026, filed 29 Apr 2026.